The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons
Research Synthesis Methods · 2026
DOI: 10.1017/rsm.2025.10059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Synthesis Methods, 2026. Verfasst von Ziren Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics and Health Data Science, https://ror.org/017zqws13University of Minnesota Twin Cities, Minneapolis, USA. Hauptthemen laut MEDLINE: Proportional Hazards Models. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Indirect treatment comparison (ITC) is widely used to estimate the comparative effectiveness of treatments when head-to-head trials are unavailable. For the typical scenario of anchored ITC where one trial compares drug A to drug C (AC trial) and another compares drug B to drug C (BC trial), the comparative effectiveness of drugs A versus B is calculated by subtracting (or dividing) the relative treatment effect of A versus C in the AC trial by that of B versus C in the BC trial, assuming the covariate distributions in both trials are balanced. This operation is valid only if the chosen effect measure is transitive, that is, in a three-arm randomized trial of drugs A, B, and C, the direct treatment effect of A versus B equals the indirect treatment effect of A versus B through their comparisons to C. For survival outcomes, many ITCs use the hazard ratio (HR) as the effect measure. In this article, we demonstrate that HR is generally not transitive and should be used with caution. As more reliable alternatives, we recommend effect measures with better transitivity properties: the restricted mean survival time (RMST) difference, the landmark survival probability difference (or ratio) at a prespecified time point, and the average hazard with survival weights (AH-SW) difference.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biostatistics and Health Data Science, https://ror.org/017zqws13University of Minnesota Twin Cities, Minneapolis, USA.
- Medical Affairs and Health Technology Assessment Statistics, Data and Statistical Sciences, https://ror.org/02g5p4n58AbbVie Inc, USA.
- Data Sciences and Analytics, https://ror.org/01xdqrp08Pfizer Inc, USA.
- Department of Biostatistics, Epidemiology and Informatics, https://ror.org/04h81rw26University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
- The Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Ziren Jiang, Joseph Cappelleri
Zitieren
APA
Jiang, Z., Liu, J., He, W., Cappelleri, J., Roychoudhury, S., Chen, Y., & Chu, H. (2026). The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons. Research Synthesis Methods. https://doi.org/10.1017/rsm.2025.10059
Vancouver
Jiang Z, Liu J, He W, Cappelleri J, Roychoudhury S, Chen Y, et al. The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons. Research Synthesis Methods. 2026. doi:10.1017/rsm.2025.10059
BibTeX
@article{Jiang2026,
author = {Jiang, Ziren and Liu, Jialing and He, Weili and Cappelleri, Joseph and Roychoudhury, Satrajit and Chen, Yong and Chu, Haitao},
title = {The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons},
journal = {Research Synthesis Methods},
year = {2026},
doi = {10.1017/rsm.2025.10059}
}
EUVIMED